Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. May 28, 2020; 26(20): 2645-2656
Published online May 28, 2020. doi: 10.3748/wjg.v26.i20.2645
Table 1 Demographic and clinical characteristics of patients and healthy controls
Healthy controls (n = 9)Patients without HCC (n = 25)Patients with HCC (n = 16)P value
Sex (males)4 (44.4%)12 (48.0%)13 (81.3%)0.072
Age, yr27.6 (25-34)42.8 (20-77)60.8 (34-77)< 0.001c
Hemoglobin (g/dL)13.3 ± 1.512.1 ± 1.90.082
Hematocrit (%)41.4 ± 4.136.7 ± 5.70.008b
Platelets count (103/µL)246.4 ± 56.7180.1 ± 80.80.007b
White cell count (103/µL)6.5 ± 2.26.1 ± 2.00.59
INR1.0 ± 0.11.1 ± 0.20.34
AST (U/L)48.9 ± 42.280.0 ± 65.00.07
ALT (U/L)75.8 ± 83.156.9 ± 32.30.407
ALP (mg/L)59.3 ± 14.3177.5 ± 118.00.066
Total bilirubin (mg/dL)0.7 ± 0.10.8 ± 0.40.757
Albumin (g/dL)4.5 ± 0.33.4 ± 0.60.001b
AFP (IU/mL)2.4 ± 2.24810.2 ± 10236.10.531
log10 HBV DNA (IU/mL)5.4 ± 2.63.0 ± 1.90.066
BAFF (pg/mL)914.8 ± 159.31208.8 ± 386.10.042a
BCLC stage
A-B12 (75.0%)
C4 (25.0%)